Tiadylt ER is a prescription medication used to treat two conditions: high blood pressure (hypertension) and chronic stable angina, which is recurring chest pain triggered by physical activity or stress. The active ingredient is diltiazem hydrochloride, a calcium channel blocker that relaxes blood vessels and reduces how hard the heart has to work. The “ER” stands for extended release, meaning the capsule delivers the medication gradually throughout the day so you only need to take it once daily.
How Tiadylt ER Works
Tiadylt ER lowers blood pressure by blocking calcium from entering the smooth muscle cells that line your blood vessels. Without that calcium signal, the muscles relax, the vessels widen, and resistance to blood flow drops. The result is lower blood pressure with less strain on the heart.
For people with chronic stable angina, the same mechanism helps in a slightly different way. By widening the coronary arteries (the vessels that supply blood to the heart muscle), the drug improves blood flow to the heart. It also slows the heart rate and reduces the force of each heartbeat, which means the heart needs less oxygen overall. That combination reduces the chest pain episodes that come with angina.
Available Doses and How to Take It
Tiadylt ER capsules come in six strengths: 120, 180, 240, 300, 360, and 420 mg. Your prescriber will typically start at a lower dose and adjust upward based on how your blood pressure or angina responds. It can be used on its own for blood pressure or combined with other blood pressure medications.
You can take Tiadylt ER with or without food. A high-fat meal does not change how much of the drug your body absorbs, though peak levels may arrive slightly sooner. If you have trouble swallowing capsules, the capsule can be opened and the contents sprinkled onto a spoonful of applesauce. Swallow the applesauce right away without chewing, then follow it with a glass of cool water. Do not crush or chew the beads inside the capsule, as that would release the medication all at once instead of gradually.
If you’ve been taking a different form of diltiazem (such as an immediate-release tablet), switching to Tiadylt ER at the nearest equivalent total daily dose is considered safe.
Where It Fits Among Blood Pressure Medications
Diltiazem belongs to a subclass called nondihydropyridine calcium channel blockers. According to the 2025 AHA/ACC hypertension guidelines, this subclass is considered an alternative rather than a first-line option. The four first-line classes for most people are thiazide-type diuretics, long-acting dihydropyridine calcium channel blockers (a different subclass), ACE inhibitors, and ARBs. Tiadylt ER is generally prescribed when those first-line options aren’t suitable or when its heart-rate-lowering effect offers an added benefit, such as in angina.
Common Side Effects
In placebo-controlled clinical trials, the most frequently reported side effects at standard doses (up to 360 mg daily) were:
- Headache: about 8% of patients, compared to 2% on placebo
- Swelling in the legs or ankles: about 5%, compared to 2% on placebo
- Indigestion: about 5%, versus 0% on placebo
- Dizziness: about 4%
- Flushing or feeling warm: about 3%
- Skin rash: about 2%
- Palpitations: about 1 to 2%
At higher doses (480 to 540 mg daily), ankle swelling became notably more common, affecting up to 15% of patients. Dizziness also increased to about 10% at those higher doses. Most side effects are mild and tend to be dose-related, meaning they’re more likely as the dose goes up.
Who Should Not Take Tiadylt ER
Tiadylt ER is not safe for everyone. It is specifically contraindicated in people with:
- Sick sinus syndrome (unless you have a pacemaker), a condition where the heart’s natural pacemaker doesn’t fire properly
- Second- or third-degree heart block (again, unless a pacemaker is in place), where electrical signals between the upper and lower chambers of the heart are delayed or blocked
- Very low blood pressure, defined as a systolic reading below 90 mmHg
- Heart failure with reduced pumping ability (HFrEF), because the drug further weakens the heart’s contracting force
- Recent heart attack with fluid in the lungs
Current guidelines also warn against routinely combining Tiadylt ER with beta-blockers. Both drug classes slow the heart rate, and using them together raises the risk of an excessively slow heartbeat or heart block. Diltiazem also interacts with a wide range of other medications because it affects a key liver enzyme (CYP3A4) involved in breaking down many drugs. If you take other prescriptions, your pharmacist or prescriber will check for interactions before starting Tiadylt ER.
How It Differs From Immediate-Release Diltiazem
The extended-release formulation uses tiny beads inside the capsule that dissolve at different rates, keeping diltiazem levels steady in your bloodstream over a full day. About 93% of the drug is absorbed from the ER capsule compared to the same total daily dose given as immediate-release tablets taken multiple times a day. The elimination half-life ranges from 4 to 9.5 hours, with an average of about 6.5 hours, but the sustained-release design means one daily dose is enough.
One important pharmacological detail: Tiadylt ER has nonlinear absorption. Increasing the dose from 120 mg to 540 mg (a 4.5-fold increase) produces a roughly 6- to 8-fold increase in drug levels in the blood. That means higher doses have a disproportionately stronger effect, which is one reason dose increases are made carefully and gradually.